Trial Profile
Interventional, Multicenter, Prospective, Randomized Trial to Slow Down the Progression of Cardiovascular Calcifications to Reduce QTd in Incident Dialysis Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jan 2018
Price :
$35
*
At a glance
- Drugs Sevelamer (Primary) ; Calcium carbonate
- Indications Vascular calcification
- Focus Therapeutic Use
- Acronyms Independent
- 14 Sep 2015 New trial record